Journal of Chronic Fatigue Syndrome: Volume 2, Issue 2-3, 1996

Titles and abstracts for the Journal of Chronic Fatigue Syndrome, Volume 2, Issue 2-3, 1996.

Volume 2, Issue 2-3, 1996

• Poster Session II
• Symposium B: Related Disorders - Gulf War Syndrome
• Session X: CFS - Natural History and Epidemiology

• Natural Course of CFS and Its Predictors by G. Bleijenberg, J.N.H.M. Vercoulen, E. Bazelmans, C.M.A. Swanink, J.F.M. Fennis, J.M.D. Galama, and J.W.M. van der Meer.
• The Natural History of CFS in the CDC Surveillance System by J.G. Dobbins, M. Reyes, N. Cole, P.L. Stee1, B. Randall, and W.C. Reeves.
• Demographic Data on Patients with Chronic Fatigue Syndrome University Hospital in Stockholm by B. Evengård, G. Lindh, L. Lindqvist, and R. Olin.

• Session IX: CFS - Treatment

• A Review of the Use of Antiviral and Immuno-modulating Drugs in the Treatment of Chronic Fatigue Syndrome by K. De Meirleir;
• A New Model for Handling CFS Patients at an Out-Patient Department of Infectious Diseases in Sweden by R. Engqvist, C. Hedenstedt, B. Evengård, G. Lindh, L. Lindqvist, and R. Olin;
• An Overview of Clinical Experience in the U.S.A. with Ampligen® (Poly I:Poly C12U) in the Treatment of Chronic Fatigue Syndrome by D.R. Strayer and W.A. Carter.

• Poster Session I
• Session VIII: CFS - Clinical Observations

• Symptom Perceptions and Quality of Life in Patients with Chronic Fatigue Syndrome (CFS) and GI Disorders by H. Hyrnan and T. Wasser.

• Session VII: CFS - Neuropsychology

• Generalized Anxiety Disorder in the Chronic Fatigue Syndrome by B. Fischler, R. Cluydts, V. De Gucht, L. Kaufman, and K. De Meirleir;
• The Cardiff Chronic Fatigue Study - The First 300 Patients by A.P. Smith, L.K. Borysiewicz, J. Pollack, and M. Thomas;
• Psychic and Psychosomatic Complaints in CFS Patients by U.T. Egle, W. Nix, and R. Schwab;
• Neurasthenia Revisited: ICD-10 and DSMIIIR Psychiatric Syndrome and Chronic Fatigue Syndrome Patients and Controls by A. E. Farmer, I. Jones, J. Hillier, M. Llewellyn, L. Borysiewicz, and A. Smith;
• Analysis of Aspects of Personality and Life Style in Chronic Fatigue Syndrome by E. R. Neerinckx, B. Van Houdenhove, H. Bobbaers, andD. Blockmans.

• Session VI: CFS - Functional Neuro-Imaging

• Radionuclide Brain Imaging in Patients with Myalgic Encephalomyelitis and Chronic Fatigue Syndrome (CFS) byD.C. Costa.

• Session V: CFS - Immunology

• Immunopathogenesis of Chronic Fatigue Syndrome by N.G. Klimas
• Immunologic Abnormalities in Chronic Fatigue Syndrome by U. Tirelli, M. Tavio, and A. Pinto;
• Chronic Fatigue Syndrome: Evaluation of a 30-Criteria-Score and Correlation with Immune Activation by A. Hilgers and J. Frank;
• Lymphocyte Subsets, Apoptosis and Cytokines in Patients with the Chronic Fatigue Syndrome by C.M.A. Swanink, J.H.M.M. Vercnulen, J. M.D. Galama, M. T. L. Roos, L. Meyaard, J. van der Ven-Jongekrijg, R. de Nijs, G. Bleijenberg, J.F.M. Fernis, F. Miedema, and J.W.M. van der Meer

• Session IV: CFS - Microbiologic Pathogenesis

• Microbial Pathogens as a Cause of CFS by J.M.D. Galama, C.M.A. Swanink, J.H.M.M. Vercoulen, J.F.M. Fennis, G. Bleijenberg, and J.W.M. van der Meer;
• Borna Disease Virus in the Atlanta CFS Case-Control Study by J.G. Dobbins, W.I. Lipkin, C. Even, A.C. Mawle;
• Demonstration of Borna Disease Virus RNA in peripheral blood mononuclear cells from Japanese Patients with CFS by K. Ikuta, T. Nakaya, H. Takahashi, Y. Nakamura, S. Asahi, M. Tobiume, H. Kuratsune, K. Yamaguti, R. Inagi, K. Yamanishi, T. Kitani;
• Failure to Demonstrate Enterovirus in Swedish Patients with Chronic Fatigue Syndrome by G. Lindh, A. Samuelson, K.O. Hedlund, B. Evengård, L. Lindqvist, and A. Ehrnst;
• Enterovirus Replication and Chronic Fatigue Syndrome by J. W. Gow, W. M. H. Behan, P. Cash, K. Simpson,D. Kay, M.M. McGill, and P.O. Behan

• Symposium A: Related Disorders - Post-Polio Syndrome - Exercise capacity in post-polio patients
• Session III: CFS - Muscle

• Muscle Studies in Chronic Fatigue Syndrome by W.M.H. Behan;
• Identification of Enteroviral RNA Detected in Muscle Biopsies from Patients with Chronic Fatigue Syndrome of Myositis, Using Reverse Transcription-Nested Polymerase Chain Reaction and Nucleotide Sequencing by B. Sotefiou, H. Zhang,D.R. Woodrow, R.J.M. Lane, and L.C. Archard;
• Alterations in Muscles of CFS Patients at Morphological, Biochemical and Molecular Level by E. Pizzigallo, A. Di Girolamo, G. Montanari, L. Dragani, J. Vecchiet, and G. Calella

• Session II: CFS - Neuro-Endocrinology

• Neuroendocrinology of Chronic Fatigue Syndrome by T.G. Dinan
• Neuroendocrinological Studies in Patients with Chronic Fatigue Syndrome by B. Evengård, P. Eneroth, C-G. Nilsson, L Lindqvist, G. Lindh, and R. Olin;
• Preliminary Evidence for a Molecular Basis to Chronic Fatigue Syndrome by N.R.McGregor, R.H. Dunstan, M. Zerbes, H.L. Butt, T. K. Roberts, and I. J. Klineberg;
• Defective Dexamethasone Induced Growth Hormone Release in Chronic Fatigue Syndrome: Evidence for Cerebral Glucocorticoid Receptor Resistance by T. Majeed, T. G. Dinan, and P.O. Behan

• Session I: CFS Assessment

• Guidelines for Evaluating and Defining CFS by Keiji Fukuda;
• Multi-dimensional Assessment in Chronic Fatigue Syndrome by J. Vercoulen, E. Bazelmans, C. Swanink, J. Fennis, J. Galama, J. Van Der Meer, and G. Bleijenberg

• The Elusive Gulf War Syndrome
• Trial of a Selective Acetylcholinesterase Inhibitor, Galanthamine Hydrobromide, in the Treatment of Chronic Fatigue Syndrome
• Chronic Ciguatera:One Organic Cause of the Chronic Fatigue Syndrome
• Polioencephalitis and the Brain Fatigue Generator Model of Post-Viral Fatigue Syndromes
• Introduction by Peter O. Behan & Kenny De Meirleir

See also

• Journal of Chronic Fatigue Syndrome for other Issues

See chronic fatigue syndrome.

Centers for Disease Control and Prevention (CDC) - The Centers for Disease Control and Prevention is a U.S. government agency dedicated to epidemiology and public health. It operates under the auspices of the Department of Health and Human Services.

See Centers for Disease Control and Prevention.

chronic fatigue (CF) - Persistent and abnormal fatigue is a symptom, not an illness. It may be caused by depression, multiple sclerosis, fibromyalgia, chronic fatigue syndrome or many other illnesses. The term "chronic fatigue" should never be confused with the disease chronic fatigue syndrome.

somatic symptom disorder A psychiatric term to describe an alleged condition whereby a person's thoughts somehow cause physical symptoms. The actual existence of such a condition is highly controversial, due to a lack of scientific evidence. It is related to other psychiatric terms, such as "psychosomatic", "neurasthenia", and "hysteria". Older terms include "somatization", "somatoform disorder", and "conversion disorder". Such terms refer to a scientifically-unsupported theory that claims that a wide range of physical symptoms can be created by the human mind, a theory which has been criticized as "mind over matter" parapsychology, a pseudoscience.

International Classification of Diseases (ICD) - A system of medical diagnostic codes, created by the World Health Organization (WHO), to classify diseases and other health related conditions for the purpose of international diagnostic consistency. By having common diagnostic codes around the world, health researchers are better able to quantify and track disease burdens. The most current version is called ICD-11. (Learn more: www.who.int)

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

apoptosis a type of cell death in which a cell, in response to a threat, initiates a series of molecular steps that lead to its orderly death. This is one method the body uses to get rid of unneeded or abnormal cells. This form of cell suicide is also called programmed cell death.

cytokine any class of immunoregulatory proteins secreted by cells, especially immune cells. Cytokines are small proteins important in cell signaling that modulate the immune system. (Learn more: me-pedia.org)

enterovirus A genus of RNA viruses which typically enter the body through the respiratory or gastrointestinal systems and sometimes spread to the central nervous system or other parts of the body, causing neurological, cardiac, and other damage. Since the first reports of myalgic encephalomyelitis (ME), enteroviruses have been suspected as a cause of ME. Enteroviruses have also been implicated as the cause of Type I diabetes, congestive heart failure, and other conditions. Enteroviruses include poliovirus, coxsackieviruses, and many others. New enteroviruses and new strains of existing enteroviruses are continuously being discovered. (Learn more: viralzone.expasy.org)

enterovirus A genus of RNA viruses which typically enter the body through the respiratory or gastrointestinal systems and sometimes spread to the central nervous system or other parts of the body, causing neurological, cardiac, and other damage. Since the first reports of myalgic encephalomyelitis (ME), enteroviruses have been suspected as a cause of ME. Enteroviruses have also been implicated as the cause of Type I diabetes, congestive heart failure, and other conditions. Enteroviruses include poliovirus, coxsackieviruses, and many others. New enteroviruses and new strains of existing enteroviruses are continuously being discovered. (Learn more: viralzone.expasy.org)

cerebral 1. of or relating to the brain or the intellect 2. of, relating to, affecting, or being the cerebrum.